Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

The discovery of dabigatran etexilate.

van Ryn J, Goss A, Hauel N, Wienen W, Priepke H, Nar H, Clemens A.

Front Pharmacol. 2013 Feb 12;4:12. doi: 10.3389/fphar.2013.00012. eCollection 2013.

PMID:
23408233
[PubMed]
Free PMC Article
2.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9. Review.

PMID:
23292752
[PubMed - indexed for MEDLINE]
3.

Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Baetz BE, Spinler SA.

Pharmacotherapy. 2008 Nov;28(11):1354-73. doi: 10.1592/phco.28.11.1354. Review.

PMID:
18956996
[PubMed - indexed for MEDLINE]
4.

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.

Ma TK, Yan BP, Lam YY.

Pharmacol Ther. 2011 Feb;129(2):185-94. doi: 10.1016/j.pharmthera.2010.09.005. Epub 2010 Oct 12. Review.

PMID:
20920530
[PubMed - indexed for MEDLINE]
5.

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.

Dahl OE.

Vasc Health Risk Manag. 2012;8:45-57. doi: 10.2147/VHRM.S26482. Epub 2012 Jan 25. Review.

PMID:
22323896
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.

Bovio JA, Smith SM, Gums JG.

Ann Pharmacother. 2011 May;45(5):603-14. doi: 10.1345/aph.1P644. Epub 2011 May 3. Review.

PMID:
21540406
[PubMed - indexed for MEDLINE]
7.

Ximelagatran: a new oral anticoagulant.

Hrebickova L, Nawarskas JJ, Anderson JR.

Heart Dis. 2003 Nov-Dec;5(6):397-408. Review.

PMID:
14633322
[PubMed - indexed for MEDLINE]
8.

Dabigatran etexilate: A novel oral direct thrombin inhibitor.

Blommel ML, Blommel AL.

Am J Health Syst Pharm. 2011 Aug 15;68(16):1506-19. doi: 10.2146/ajhp100348. Review.

PMID:
21817082
[PubMed - indexed for MEDLINE]
9.

New options with dabigatran etexilate in anticoagulant therapy.

Maegdefessel L, Spin JM, Azuma J, Tsao PS.

Vasc Health Risk Manag. 2010 May 25;6:339-49. Review.

PMID:
20531953
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Garnock-Jones KP.

Am J Cardiovasc Drugs. 2011;11(1):57-72. doi: 10.2165/11206400-000000000-00000.

PMID:
21265583
[PubMed - indexed for MEDLINE]
11.

Advances in oral anticoagulants: focus on dabigatran etexilate.

Hazlewood KA, Weiland CM.

Expert Rev Clin Pharmacol. 2010 Nov;3(6):727-37. doi: 10.1586/ecp.10.49.

PMID:
22111776
[PubMed]
12.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
[PubMed - indexed for MEDLINE]
13.

[New anticoagulants - direct thrombin inhibitors].

Brand B, Graf L.

Ther Umsch. 2012 Nov;69(11):643-9. doi: 10.1024/0040-5930/a000342. Review. German.

PMID:
23117667
[PubMed - indexed for MEDLINE]
14.

Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.

Cheng JW, Vu H.

Clin Ther. 2012 Apr;34(4):766-87. doi: 10.1016/j.clinthera.2012.02.022. Epub 2012 Mar 22. Review.

PMID:
22444784
[PubMed - indexed for MEDLINE]
15.

[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].

Meddahi S, Samama MM.

J Mal Vasc. 2011 Feb;36(1):24-32. doi: 10.1016/j.jmv.2010.11.005. Epub 2011 Jan 15. French.

PMID:
21239127
[PubMed - indexed for MEDLINE]
16.

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

Stangier J.

Clin Pharmacokinet. 2008;47(5):285-95. Review.

PMID:
18399711
[PubMed - indexed for MEDLINE]
17.

Dabigatran etexilate: future directions in anticoagulant treatment.

Schulman S, Reilly PA.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:32S-41S. doi: 10.1177/1076029609344199. Epub 2009 Aug 13. Review.

PMID:
19679590
[PubMed - indexed for MEDLINE]
18.

The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

Mavrakanas T, Bounameaux H.

Pharmacol Ther. 2011 Apr;130(1):46-58. doi: 10.1016/j.pharmthera.2010.12.007. Epub 2010 Dec 24. Review.

PMID:
21185864
[PubMed - indexed for MEDLINE]
19.

Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.

Agnelli G, Sonaglia F, Becattini C.

Curr Pharm Des. 2005;11(30):3885-91. Review.

PMID:
16305519
[PubMed - indexed for MEDLINE]
20.

Dabigatran etexilate: a new thrombin inhibitor.

Verma AK.

Med J Aust. 2010 Apr 5;192(7):407-12.

PMID:
20367591
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk